Astragaloside IV: a potential nemesis for gastric cancer

Astragaloside IV: a potential nemesis for gastric cancer

Gastric cancer (GC), a life-threatening malignancy with profound global health impacts, remains a cardinal focus of biomedical research. Recently, astragaloside IV (AS-IV), a bioactive triterpenoid saponin derived from Astragalus mongholicus Bunge, has garnered substantial attention for its multifac...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chao Hu, Qiong Li, Song-Nan Gong, Xiao-Jie Zou, Jia-Yue Xu, Hai-Feng Ying, Lan Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	gastric cancer astragaloside IV apoptosis mechanisms review
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1636341/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The protective effect of astragaloside IV on puromycin aminonucleoside induced podocyte injury and its potential mechanism
by: GONG Jian-guang, et al.
Published: (2020-01-01)

Astragaloside-IV Inhibits Metastasis by Suppressing the SDF-1/CXCR4 Axis and Activating Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells
by: Burçin İrem Abas, et al.
Published: (2024-05-01)

Astragaloside IV represses hepatocellular carcinoma progression by modulating HMGB1-ferroptosis axis
by: Xingyang Zhao, et al.
Published: (2025-08-01)

Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol
by: Bei-Bei Xiong, et al.
Published: (2025-05-01)

Therapeutic effects and potential mechanisms of astragaloside IV on pulmonary fibrosis: a systematic review and meta-analysis of preclinical studies
by: Shujuan Zhang, et al.
Published: (2025-07-01)

Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review
by: Meilian Chen, et al.
Published: (2025-04-01)

Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction
by: Sha Zhongxin, et al.
Published: (2025-07-01)

Astragaloside IV alleviated bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and fecal metabolism
by: Huichao Wang, et al.
Published: (2025-04-01)

Astragaloside IV attenuates podocyte apoptosis via regulating TXNIP/NLRP3/GSDMD signaling pathway in diabetic nephropathy
by: Zhibo Hu, et al.
Published: (2024-12-01)

Astragaloside IV relieves passive heymann nephritis and podocyte injury by suppressing the TRAF6/NF-κb axis
by: Yuhua Ma, et al.
Published: (2024-12-01)

Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic
by: Fengge Wang, et al.
Published: (2025-01-01)

Astragaloside IV regulates FOXM1 deubiquitination to ameliorate trophoblast damage caused by high glucose
by: Fan Li, et al.
Published: (2025-06-01)

Astragaloside IV as a promising therapeutic agent for liver diseases: current landscape and future perspectives
by: Chunyan Chen, et al.
Published: (2025-04-01)

Astragaloside IV- loaded biomimetic nanoparticles target IκBα to regulate neutrophil extracellular trap formation for sepsis therapy
by: Shujuan Wu, et al.
Published: (2025-02-01)

Astragaloside IV accelerates hematopoietic reconstruction by improving the AMPK/PGC1α-mediated mitochondrial function in hematopoietic stem cells
by: Ling Zhang, et al.
Published: (2025-04-01)

Oxymatrine and astragaloside IV co-loaded liposomes: Scale-up purposes and their enhancement of anti-PD-1 efficacy against breast cancer
by: Liangyin Wei, et al.
Published: (2025-06-01)

Astragaloside IV mitigates influenza-induced inflammatory responses by suppressing the Wnt/β-catenin signalling pathway in alveolar macrophages
by: Jianli Tang, et al.
Published: (2025-04-01)

Astragaloside IV promotes the pyroptosis of airway smooth muscle cells in childhood asthma by suppressing HMGB1/RAGE axis to inactivate NF-κb pathway
by: Huahong Zhang, et al.
Published: (2024-07-01)

The gut–kidney axis is regulated by astragaloside IV to inhibit cyclosporine A-induced nephrotoxicity
by: Cong Han, et al.
Published: (2025-01-01)

Combination astragaloside IV and artesunate preserves blood–brain barrier integrity by modulating astrocytes and tight junction proteins in Plasmodium yoelii infection
by: Phornyupa Sanguanwong, et al.
Published: (2025-08-01)

Effects of Radix Astragali on renal proximal tubular epithelial cells-induced monocytes differentiation
by: LI Qing, et al.
Published: (2016-01-01)

Astragaloside IV Promotes Osteogenic Differentiation of Periodontal Ligament Stem Cells via Activating PI3K/AKT/eNOS/NO Signaling Pathway: In vitro and in vivo Study
by: Song Y, et al.
Published: (2025-07-01)

Research on the mechanism of Astragaloside Ⅳ in regulating urotensin Ⅱ-induced renal tubular epithelial cells injury through the RhoA/ROCK1 signaling pathway
by: Liu Qian-wei, et al.
Published: (2025-03-01)

Research on the mechanism of Astragaloside Ⅳ in regulating urotensin Ⅱ-induced renal tubular epithelial cells injury through the RhoA/ROCK1 signaling pathway
by: Liu Qian-wei, et al.
Published: (2025-03-01)

Exploratory review on the effect of Astragalus mongholicus on signaling pathways
by: Inmaculada Xu Lou, et al.
Published: (2024-12-01)

Bacteria-based drug-loaded mesoporous silica nanoparticles for synergistic FUAS of breast cancer
by: Mingyang Zhang, et al.
Published: (2025-05-01)

Mechanism of astragaloside A against lung adenocarcinoma based on network pharmacology combined with molecular dynamics simulation technique
by: Jian Ding, et al.
Published: (2025-04-01)

Astragaloside II pretreatment alleviates PM2.5-induced lung injury in mice via MAPK/Nrf2/GPX4 axis-mediated suppression of ferroptosis
by: Liyun Liu, et al.
Published: (2025-09-01)

Association between the geriatric nutritional risk index and postoperative delirium in gastric surgery patients: an analysis of the MIMIC-IV database
by: Yan Chen, et al.
Published: (2024-12-01)

Unveiling the chemotherapeutic potential of two platinum(IV) complexes in skin cancer: in vitro and in vivo Insights
by: Amjad Slika, et al.
Published: (2024-01-01)

Anti-fibrosis effect of astragaloside IV in animal models of cardiovascular diseases and its mechanisms: a systematic review
by: Shiyu Zhang, et al.
Published: (2025-12-01)

Cytotoxicity Effect of Bifidobacterium bifidum probiotic Cell Extract and supernatants on Adenocarcinoma gastric Cancer Cell Line and Analysis of some Apoptosis Genes Expression
by: Hanieh Hemmatian, et al.
Published: (2024-11-01)

Oncolytic avian reovirus-sensitized tumor infiltrating CD8+ T cells triggering immunogenic apoptosis in gastric cancer
by: Yi-Ying Wu, et al.
Published: (2024-10-01)

Platinum(IV) anticancer therapies and cathepsin B: innovative strategies for overcoming resistance in glioblastoma cells
by: Claudio Casali, et al.
Published: (2025-06-01)

Comparative immunohistochemical characteristics of Ki-67, p53, caspase-3 expression in gastric hyperplastic polyps and non-invasive intestinal-type gastric adenocarcinoma
by: T. A. Khrystenko
Published: (2016-08-01)

Alba Nemesis
by: Irene Maria Dietschi
Published: (1979-01-01)

The concept of nemesis in psychoneurosis O conceito de nemesis em psiconeurose
by: A. H. Chapman, et al.
Published: (1997-09-01)

Oleandrin Promotes Apoptosis in an Autophagy-Dependent Manner in Gastric Cancer
by: Xiaoyan Huang, et al.
Published: (2025-05-01)

Organic Moiety on Sn(IV) Does Matter for In Vitro Mode of Action: <i>n</i>Bu<sub>3</sub>Sn(IV) Compounds with Carboxylato <i>N</i>-Functionalized 2-Quinolones Induce Anoikis-like Cell Death in A375 Cells
by: Marijana P. Kasalović, et al.
Published: (2024-11-01)

Identification and dipeptidyl peptidase IV (DPP-IV) inhibitory activity verification of peptides from mouse lymphocytes
by: Juan Wang, et al.
Published: (2022-11-01)